Sabra Health Care REIT (SBRA) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

SBRA Stock Forecast


Sabra Health Care REIT stock forecast is as follows: an average price target of $18.00 (represents a 6.13% upside from SBRA’s last price of $16.96) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.

SBRA Price Target


The average price target for Sabra Health Care REIT (SBRA) is $18.00 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $20.00 to $16.00. This represents a potential 6.13% upside from SBRA's last price of $16.96.

SBRA Analyst Ratings


Hold

According to 9 Wall Street analysts, Sabra Health Care REIT's rating consensus is 'Hold'. The analyst rating breakdown for SBRA stock is 0 'Strong Buy' (0.00%), 4 'Buy' (44.44%), 5 'Hold' (55.56%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Sabra Health Care REIT Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 12, 2024Nicholas JosephCitigroup$20.00$18.358.99%17.92%
Sep 03, 2024Michael LewisTruist Financial$18.00$17.005.88%6.13%
Jun 21, 2024David RodgersRobert W. Baird$16.00$14.559.97%-5.66%
May 15, 2024Nicholas YulicoScotiabank$15.00$14.672.25%-11.56%
May 31, 2023Omotayo OkusanyaCredit Suisse$13.00$10.6821.72%-23.35%
Dec 27, 2021Michael R LewisTruist Financial$16.00$13.1022.14%-5.66%
Aug 24, 2021Jonathan PetersenJefferies$19.00$15.3523.78%12.03%
May 04, 2021Daniel BernsteinCapital One Financial$20.00$16.4321.73%17.92%

The latest Sabra Health Care REIT stock forecast, released on Sep 12, 2024 by Nicholas Joseph from Citigroup, set a price target of $20.00, which represents a 8.99% increase from the stock price at the time of the forecast ($18.35), and a 17.92% increase from SBRA last price ($16.96).

Sabra Health Care REIT Price Target by Period


1M3M12M
# Anlaysts--4
Avg Price Target--$17.25
Last Closing Price$16.96$16.96$16.96
Upside/Downside-100.00%-100.00%1.71%

In the current month, the average price target of Sabra Health Care REIT stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sabra Health Care REIT's last price of $16.96. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 11, 2024ScotiabankSector PerformSector PerformHold
Sep 12, 2024CitigroupNeutralBuyUpgrade
Aug 26, 2024ScotiabankSector PerformSector PerformHold
Aug 23, 2024Wells FargoEqual-WeightEqual-WeightHold
May 21, 2024CitigroupNeutralNeutralHold
May 15, 2024ScotiabankSector PerformSector PerformHold
Oct 10, 2023Bank of America SecuritiesNeutralBuyUpgrade
Sep 20, 2023JefferiesBuyUpgrade
Aug 11, 2023Bank of America SecuritiesNeutralUpgrade
May 31, 2023Morgan StanleyEqual-WeightEqual-WeightHold
May 15, 2023Credit SuisseNeutralNeutralHold
Dec 13, 2022JMP SecuritiesMarket PerformDowngrade
May 25, 2022Mizuho SecuritiesBuyUpgrade

Sabra Health Care REIT's last stock rating was published by Scotiabank on Oct 11, 2024. The company gave SBRA a "Sector Perform" rating, the same as its previous rate.

Sabra Health Care REIT Financial Forecast


Sabra Health Care REIT Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$163.40M$161.63M$161.17M$161.32M$164.99M$140.76M$155.96M$163.10M$135.66M$128.59M$152.93M$152.37M$152.05M$143.25M$153.92M$149.35M$155.76M$149.83M
Avg Forecast$198.08M$196.35M$193.59M$191.85M$189.38M$176.26M$182.46M$179.77M$176.79M$172.67M$166.54M$160.40M$162.91M$160.30M$158.72M$159.13M$154.07M$154.30M$156.07M$153.02M$150.10M$151.57M$152.94M$149.87M$152.20M$151.16M$145.92M$153.14M$148.89M$113.34M
High Forecast$206.95M$205.13M$202.25M$200.43M$197.85M$184.15M$190.62M$182.87M$180.36M$173.99M$166.54M$160.40M$166.04M$160.30M$165.83M$166.25M$160.96M$154.30M$156.07M$153.02M$150.10M$151.57M$152.94M$149.87M$152.20M$151.16M$145.92M$153.14M$148.89M$113.34M
Low Forecast$188.43M$186.78M$184.15M$182.50M$180.15M$167.67M$173.57M$174.75M$170.42M$171.36M$166.54M$160.40M$160.82M$160.30M$150.99M$151.37M$146.56M$154.30M$156.07M$153.02M$150.10M$151.57M$152.94M$149.87M$152.20M$151.16M$145.92M$153.14M$148.89M$113.34M
# Analysts222211143154845443435454545443
Surprise %------------1.00%1.01%1.02%1.01%1.07%0.91%1.00%1.07%0.90%0.85%1.00%1.02%1.00%0.95%1.05%0.98%1.05%1.32%

Sabra Health Care REIT's average Quarter revenue forecast for Mar 24 based on 4 analysts is $160.40M, with a low forecast of $160.40M, and a high forecast of $160.40M. SBRA's average Quarter revenue forecast represents a -1.83% decrease compared to the company's last Quarter revenue of $163.40M (Dec 23).

Sabra Health Care REIT EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211143154845443435454545443
EBITDA------------$59.54M$103.30M$101.82M$102.73M$21.87M$86.09M$104.01M$111.39M$46.93M$79.60M$-63.29M$102.97M$105.17M$105.44M$99.55M$106.13M$111.21M$94.85M
Avg Forecast$109.75M$108.79M$107.26M$106.29M$104.92M$97.66M$101.09M$99.60M$97.95M$95.67M$92.27M$98.10M$90.26M$88.81M$87.94M$89.18M$129.43M$92.03M$93.08M$81.07M$89.52M$90.40M$91.22M$109.02M$90.77M$90.16M$87.03M$126.35M$88.80M$67.60M
High Forecast$114.66M$113.65M$112.05M$111.05M$109.62M$102.03M$105.61M$101.32M$99.93M$96.40M$92.27M$117.72M$91.99M$88.81M$91.88M$107.02M$155.32M$92.03M$93.08M$97.29M$89.52M$90.40M$91.22M$130.83M$90.77M$90.16M$87.03M$151.62M$88.80M$67.60M
Low Forecast$104.40M$103.48M$102.03M$101.11M$99.81M$92.90M$96.17M$96.82M$94.42M$94.94M$92.27M$78.48M$89.10M$88.81M$83.66M$71.35M$103.55M$92.03M$93.08M$64.86M$89.52M$90.40M$91.22M$87.22M$90.77M$90.16M$87.03M$101.08M$88.80M$67.60M
Surprise %------------0.66%1.16%1.16%1.15%0.17%0.94%1.12%1.37%0.52%0.88%-0.69%0.94%1.16%1.17%1.14%0.84%1.25%1.40%

4 analysts predict SBRA's average Quarter EBITDA for Mar 24 to be $98.10M, with a high of $117.72M and a low of $78.48M. This is 64.77% upper than Sabra Health Care REIT's previous annual EBITDA (Dec 23) of $59.54M.

Sabra Health Care REIT Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211143154845443435454545443
Net Income------------$17.16M$-15.10M$21.19M$-9.49M$-84.95M$-50.06M$16.80M$40.60M$-24.35M$10.22M$-132.57M$33.45M$37.12M$36.46M$29.62M$35.22M$39.74M$23.28M
Avg Forecast$40.30M$40.30M$40.30M$40.30M$42.67M$41.88M$40.30M$39.51M$38.88M$37.14M$35.30M$46.24M$31.89M$30.82M$22.12M$42.04M$-67.16M$38.18M$36.93M$38.21M$31.26M$32.33M$36.00M$35.41M$43.24M$41.61M$34.48M$41.92M$45.58M$39.35M
High Forecast$42.64M$42.64M$42.64M$42.64M$45.15M$44.32M$42.64M$41.80M$41.03M$37.69M$35.31M$55.49M$32.83M$32.61M$23.41M$50.44M$-53.73M$38.18M$36.93M$45.86M$31.26M$32.33M$36.00M$42.50M$43.24M$41.61M$34.48M$50.31M$45.58M$39.35M
Low Forecast$37.74M$37.74M$37.74M$37.74M$39.97M$39.23M$37.74M$38.44M$37.79M$36.59M$35.29M$36.99M$30.95M$28.86M$20.72M$33.63M$-80.59M$38.18M$36.93M$30.57M$31.26M$32.33M$36.00M$28.33M$43.24M$41.61M$34.48M$33.54M$45.58M$39.35M
Surprise %------------0.54%-0.49%0.96%-0.23%1.26%-1.31%0.46%1.06%-0.78%0.32%-3.68%0.94%0.86%0.88%0.86%0.84%0.87%0.59%

Sabra Health Care REIT's average Quarter net income forecast for Mar 24 is $46.24M, with a range of $36.99M to $55.49M. SBRA's average Quarter net income forecast represents a 169.52% increase compared to the company's last Quarter net income of $17.16M (Dec 23).

Sabra Health Care REIT SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211143154845443435454545443
SG&A------------$16.68M$10.76M$9.53M$10.50M$10.85M$9.68M$8.65M$10.40M$8.24M$8.68M$8.81M$8.94M$8.11M$7.22M$8.67M$8.76M$5.51M$8.71M
Avg Forecast$11.82M$11.71M$11.55M$11.44M$11.30M$10.52M$10.88M$10.72M$10.55M$10.30M$9.93M$11.84M$9.72M$9.56M$9.47M$10.76M$22.72M$9.18M$9.28M$9.78M$8.93M$9.01M$9.10M$9.46M$9.05M$8.99M$8.68M$63.80M$8.85M$6.74M
High Forecast$12.35M$12.24M$12.07M$11.96M$11.80M$10.99M$11.37M$10.91M$10.76M$10.38M$9.93M$14.21M$9.91M$9.56M$9.89M$12.92M$27.26M$9.18M$9.28M$11.74M$8.93M$9.01M$9.10M$11.36M$9.05M$8.99M$8.68M$76.57M$8.85M$6.74M
Low Forecast$11.24M$11.14M$10.99M$10.89M$10.75M$10.00M$10.35M$10.43M$10.17M$10.22M$9.93M$9.47M$9.59M$9.56M$9.01M$8.61M$18.17M$9.18M$9.28M$7.83M$8.93M$9.01M$9.10M$7.57M$9.05M$8.99M$8.68M$51.04M$8.85M$6.74M
Surprise %------------1.72%1.13%1.01%0.98%0.48%1.05%0.93%1.06%0.92%0.96%0.97%0.94%0.90%0.80%1.00%0.14%0.62%1.29%

Sabra Health Care REIT's average Quarter SG&A projection for Mar 24 is $11.84M, based on 4 Wall Street analysts, with a range of $9.47M to $14.21M. The forecast indicates a -29.02% fall compared to SBRA last annual SG&A of $16.68M (Dec 23).

Sabra Health Care REIT EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211143154845443435454545443
EPS-------------$-0.07$0.09$-0.04$-0.37$-0.22$0.07$0.18$-0.11$0.05$-0.61$0.16$0.18$0.18$0.14$0.17$0.20$0.12
Avg Forecast$0.17$0.17$0.17$0.17$0.18$0.18$0.17$0.17$0.16$0.16$0.15$0.14$0.13$0.13$0.09$0.12$0.13$0.16$0.16$0.15$0.13$0.14$0.15$0.17$0.18$0.18$0.15$0.20$0.20$0.17
High Forecast$0.18$0.18$0.18$0.18$0.19$0.19$0.18$0.18$0.17$0.16$0.15$0.14$0.14$0.14$0.10$0.12$0.14$0.16$0.16$0.15$0.13$0.14$0.15$0.17$0.18$0.18$0.15$0.20$0.20$0.17
Low Forecast$0.16$0.16$0.16$0.16$0.17$0.17$0.16$0.16$0.16$0.15$0.15$0.14$0.13$0.12$0.09$0.11$0.12$0.16$0.16$0.15$0.13$0.14$0.15$0.17$0.18$0.18$0.15$0.20$0.20$0.17
Surprise %------------0.00%-0.50%0.96%-0.36%-2.89%-1.35%0.44%1.18%-0.82%0.36%-3.96%0.93%0.97%1.01%0.95%0.84%1.03%0.71%

According to 4 Wall Street analysts, Sabra Health Care REIT's projected average Quarter EPS for Mar 24 is $0.14, with a low estimate of $0.14 and a high estimate of $0.14. This represents a 138280.00% increase compared to SBRA previous annual EPS of - (Dec 23).

Sabra Health Care REIT Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
MPWMedical Properties Trust$3.97$6.2056.17%Hold
GMREGlobal Medical REIT$8.46$11.7538.89%Buy
NHINational Health Investors$71.77$85.0018.43%Hold
CHCTCommunity Healthcare Trust$18.85$20.006.10%Buy
SBRASabra Health Care REIT$17.65$18.001.98%Hold
LTCLTC Properties$36.51$37.001.34%Hold
HRHealthcare Realty Trust$17.51$17.00-2.91%Buy
CTRECareTrust REIT$28.53$26.50-7.12%Buy
WELLWelltower$129.23$117.33-9.21%Buy

SBRA Forecast FAQ


Is Sabra Health Care REIT a good buy?

No, according to 9 Wall Street analysts, Sabra Health Care REIT (SBRA) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 44.44% of SBRA's total ratings.

What is SBRA's price target?

Sabra Health Care REIT (SBRA) average price target is $18 with a range of $16 to $20, implying a 6.13% from its last price of $16.96. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Sabra Health Care REIT stock go up soon?

According to Wall Street analysts' prediction for SBRA stock, the company can go up by 6.13% (from the last price of $16.96 to the average price target of $18), up by 17.92% based on the highest stock price target, and down by -5.66% based on the lowest stock price target.

Can Sabra Health Care REIT stock reach $30?

SBRA's average twelve months analyst stock price target of $18 does not support the claim that Sabra Health Care REIT can reach $30 in the near future.

What are Sabra Health Care REIT's analysts' financial forecasts?

Sabra Health Care REIT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $727.86M (high $755.5M, low $696.14M), average EBITDA is $403.27M (high $418.58M, low $385.69M), average net income is $164.35M (high $173.91M, low $155.38M), average SG&A $43.42M (high $45.07M, low $41.53M), and average EPS is $0.693 (high $0.734, low $0.655). SBRA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $779.87M (high $814.76M, low $741.86M), average EBITDA is $432.08M (high $451.42M, low $411.03M), average net income is $161.19M (high $170.57M, low $150.98M), average SG&A $46.52M (high $48.61M, low $44.26M), and average EPS is $0.68 (high $0.72, low $0.637).

Did the SBRA's actual financial results beat the analysts' financial forecasts?

Based on Sabra Health Care REIT's last annual report (Dec 2023), the company's revenue was $647.51M, beating the average analysts forecast of $641.06M by 1.01%. Apple's EBITDA was $194.84M, missing the average prediction of $356.2M by -45.30%. The company's net income was $13.76M, missing the average estimation of $126.86M by -89.16%. Apple's SG&A was $47.47M, beating the average forecast of $39.51M by 20.14%. Lastly, the company's EPS was $0.0001, missing the average prediction of $0.473 by -99.98%. In terms of the last quarterly report (Dec 2023), Sabra Health Care REIT's revenue was $163.4M, beating the average analysts' forecast of $162.91M by 0.30%. The company's EBITDA was $59.54M, missing the average prediction of $90.26M by -34.04%. Sabra Health Care REIT's net income was $17.16M, missing the average estimation of $31.89M by -46.20%. The company's SG&A was $16.68M, beating the average forecast of $9.72M by 71.62%. Lastly, the company's EPS was $0.0001, missing the average prediction of $0.135 by -99.93%